minimal residual disease
Showing 9976 - 10000 of >10,000
Sickle Cell Crisis, Sickle Cell Disease Trial in Dallas (Mindfulness meditation, breathing exercises (including incentive
Recruiting
- Sickle Cell Crisis
- Sickle Cell Disease
- Mindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 17, 2022
Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)
Recruiting
- Germ Cell Tumor
- +3 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022
Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)
Recruiting
- Early Alzheimer's Disease
- Experimental: ALZ-801
- Placebo Comparator: Placebo
-
Phoenix, Arizona
- +95 more
Aug 18, 2022
Men With Prostate Cancer Cared for by "Active Surveillance
Not yet recruiting
- Prostate Cancer
- Active Surveillance
-
Houston, TexasM D Anderson Cancer Center
Apr 24, 2023
IBD, Crohn Disease, Ulcerative Colitis Trial (Decision Coach Sessions)
Not yet recruiting
- Inflammatory Bowel Diseases
- +3 more
- Decision Coach Sessions
- (no location specified)
Jan 16, 2023
Dementia, Mild, Cognitive Disorder Mild Trial in Hwaseong-si, Seongnam-si (Neuclare)
Recruiting
- Dementia, Mild
- Cognitive Disorder Mild
- Neuclare
-
Hwaseong-si, Gyeonggi-do, Korea, Republic of
- +1 more
Nov 21, 2022
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Scottsdale, Arizona
- +14 more
Jun 30, 2022
Prostatic Tumor Trial in Rome (salvage SBRT)
Recruiting
- Prostatic Neoplasm
- salvage SBRT
-
Rome, ItalyRegina Elena National Cancer Institute
Dec 19, 2022
Alzheimer Dementia, Late Onset Alzheimer, Neurodegenerative Diseases Trial (Allopregnanolone, Placebo)
Not yet recruiting
- Alzheimer Dementia
- +2 more
- Allopregnanolone
- Placebo
- (no location specified)
May 23, 2022
Gut Microbiome With Neonatal Complications and Neurodevelopment
Recruiting
- Preterm Infants
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 23, 2022
Chronic Kidney Diseases Trial (cardiovascular exercise, Muscle strength, Mixed)
Not yet recruiting
- Chronic Kidney Diseases
- cardiovascular exercise
- +2 more
- (no location specified)
May 18, 2022
Parkinson Disease Trial in Birmingham (Protein Redistribution Diet, Protein Consistent Diet)
Not yet recruiting
- Parkinson Disease
- Protein Redistribution Diet
- Protein Consistent Diet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 23, 2022
Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar
Recruiting
- Hepatic Impairment
- +2 more
- Saroglitazar Magnesium 1 mg
- Saroglitazar Magnesium 2 mg
-
Indianapolis, IndianaIndiana University
Apr 23, 2022
Crohn's Disease Trial (Vedolizumab IV, Placebo)
Not yet recruiting
- Crohn's Disease
- Vedolizumab IV
- Placebo
- (no location specified)
Apr 20, 2023
Heart Failure, Coronary Artery Disease Trial in Brussels (3/7 Resistance Training Method, 3X9 Resistance Training Method)
Recruiting
- Heart Failure
- Coronary Artery Disease
- 3/7 Resistance Training Method
- 3X9 Resistance Training Method
-
Brussels, BelgiumErasme Hospital
Jan 20, 2023
Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)
Not yet recruiting
- Pneumococcal Infection
- V116
- +3 more
- (no location specified)
Jan 13, 2023
Kidney Transplantation in Highly Sensitized Patients Trial in Prague, Barcelona, Madrid (Imlifidase, Normal Transplantation
Recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- Normal Transplantation Routine
-
Vienna, Austria
- +9 more
Jan 24, 2023
HIV/AIDS, Hypertension, Hyperlipidemias Trial in Durham, Cleveland (Multi-component intervention, General prevention education)
Completed
- HIV/AIDS
- +2 more
- Multi-component intervention
- General prevention education
-
Durham, North Carolina
- +2 more
Jan 23, 2023
Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)
Active, not recruiting
- Metastatic Breast Cancer
-
Hospitalet de Llobregat, Barcelona, Spain
- +6 more
Jan 23, 2023
Thyroid Diseases Trial in Madison (Prednisone)
Completed
- Thyroid Diseases
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Oct 4, 2022
Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)
Recruiting
- Metastatic NSCLC
- Pembrolizumab before randomization
- +3 more
-
Aix-en-Provence, France
- +37 more
Jul 26, 2022